By Yasin Ebrahim
Investing.com – The Trump administration is reportedly asking states to waive certain requirements to speed up the approval for coronavirus vaccine sites by Nov.1, The Wall Street Journal reported.
“CDC urgently requests your assistance in expediting applications for these distribution facilities and, if necessary, asks that you consider waiving requirements that would prevent these facilities from becoming fully operational by November 1, 2020,” the CDC wrote in letter to state governors, according to the report.
The move marked the latest sign that the Trump administration is seeking to get a vaccine approval before the U.S. election on Nov. 3.
Moderna (NASDAQ:), the front runner in the race to find a Covid-19 vaccine, was flat in after-hours trade, while rivals Novavax (NASDAQ:), Pfizer (NYSE:) and Johnson & Johnson (NYSE:) were also largely unchanged.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.